(No ratings)
Dr. Pernilla Schweitzer, MD is an addiction psychiatrist in San Francisco, CA specializing in addiction psychiatry, psychotherapy, psychiatry, addiction medicine and mental health. She graduated from Columbia University, College of Physicians and Surgeons in 2011 and has 13 years of experience. Dr. Pernilla Schweitzer, MD is affiliated with LifeStance Health.
490 Post Street Suite 1043
San Francisco, CA 94102
Connecting with a therapist can be difficult. BetterHelp can help with that. They have an online network of licensed and accredited psychologists, marriage and family therapists, clinical social workers, and counselors. You can connect with their therapists via online video, phone, real-time chat, or asynchronous messaging. Easily switch therapists until you find one that fits you. Sign up through DocSpot for a discount on your first month's subscription.
Dr. Pernilla Schweitzer, MD graduated from Columbia University, College of Physicians and Surgeons in 2011. She is certified by the American Board of Psychiatry and Neurology - Addiction Psychiatry and has a state license in California.
Medical School: Columbia University, College of Physicians and Surgeons (2011)
Board Certification: American Board of Psychiatry and Neurology - Addiction Psychiatry
Licensed In: California
Dr. Pernilla Schweitzer, MD is associated with these hospitals and organizations:
Dr. Pernilla Schweitzer, MD appears to accept the following insurance providers: Blue Shield of CA, Cigna, Anthem Blue Cross of CA, Optum, Aetna, MHN and Magellan.
According to our sources, Dr. Pernilla Schweitzer, MD accepts the following insurance providers:
Dr. Pernilla Schweitzer, MD does not have any reviews yet, be the first to leave a review of Dr. Pernilla Schweitzer, MD here: Leave a Review
(No ratings)
Dr. Pernilla Schweitzer specializes in general practice, addiction psychiatry, and addiction medicine. Dr. Schweitzer studied medicine at Columbia University, College of Physicians and Surgeons. Her practice in San Francisco, CA is open to new patients as reported by Yext.